首页> 外文期刊>International Journal of Vascular Medicine >Determinants of Intravascular Resistance in Indian Diabetic Nephropathy Patients: A Hospital-Based Study
【24h】

Determinants of Intravascular Resistance in Indian Diabetic Nephropathy Patients: A Hospital-Based Study

机译:印度糖尿病肾病患者血管内耐药的决定因素:一项基于医院的研究

获取原文
           

摘要

Aims and Objectives. Metabolic dysregulation has failed to explain clinical variability of patients with diabetic nephropathy and hence a renewed interest emerged in haemodynamic factors as determinant of progression and development of diabetic nephropathy. We therefore studied for various factors which can correlate with raised renal vascular resistance in diabetic nephropathy.Material and Methods. Renal vascular resistance was measured in patients with established and incipient diabetic nephropathy and compared with controls using noninvasive color Doppler examinations of intrarenal vasculature.Results. Renal vascular resistance correlated with age, duration of disease, GFR, serum creatinine, and stage of retinopathy. Renal vascular resistance was significantly reduced in patients on treatment with RAAS inhibitors and insulin, than those on OHA and antihypertensives other than RAAS inhibitors.Conclusion. The study implies that renal vascular resistance may help identify diabetics at high risk of developing nephropathy, and these set of patients could be candidates for RAAS inhibition and early insulin therapy even in patients without albuminuria.
机译:目的和目标。代谢失调未能解释糖尿病性肾病患者的临床变异性,因此,对于决定糖尿病性肾病进展和发展的血流动力学因素的新兴趣正在兴起。因此,我们研究了与糖尿病肾病中与肾血管阻力升高相关的各种因素。材料与方法。对已确诊和初发的糖尿病性肾病患者进行肾血管阻力测定,并通过无创彩色多普勒检查肾内血管系统将其与对照组进行比较。肾血管阻力与年龄,疾病持续时间,GFR,血清肌酐和视网膜病变阶段有关。接受RAAS抑制剂和胰岛素治疗的患者的肾血管阻力显着降低,优于使用OHA和非RAAS抑制剂的抗高血压药的患者。该研究表明,肾血管阻力可能有助于确定处于发展性肾病高风险状态的糖尿病患者,并且这些患者甚至可以在没有蛋白尿的患者中进行RAAS抑制和早期胰岛素治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号